Sierra Oncology

Sierra Oncology is a California-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.

Business Model:

Revenue: $300k

Employees: 51-200

Detailed Sierra Oncology Information

Sierra Oncology was acquired by GlaxoSmithKline.
The acquisition happend on 2022-04-13.
Details of the transaction were not public

Acquirer

Geographic Data

Sierra Oncology headquarters map

Address: 1820 Gateway Drive

City: San Mateo

State: CA

Zip: 94404

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$135M

Raised Total:

$272M

Metrics

3,595,987Website Global Rank

3,748Website Monthly Traffic

Twitter Followers

Description

Sierra Oncology is a California-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.

Contact Phone:
+16503768679

Contact Email:

Sierra Oncology went public on 7/9/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/9/2015

IPO Valuation:
$410M

Ticker Symbol:
SRRA

IPO Price:
$14/share

Amount Raised:
$107M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2005 Venture Round 2 $1.1M Orchard Venture Partners
Apjohn ventures
Orchard Venture Partners
Apjohn ventures
4/2014 Series D $0 Frazier Healthcare Partners
RA Capital Management
Hopen Life Science Ventures
Capital Midwest Fund
Apjohn ventures
Vivo Capital
Janus Capital Group
The Amherst Fund
OrbiMed
Vivo Capital
Frazier Healthcare Partners
RA Capital Management
Hopen Life Science Ventures
Capital Midwest Fund
Apjohn ventures
Vivo Capital
Janus Capital Group
The Amherst Fund
OrbiMed
Vivo Capital
5/2008 Venture Round $0 Apjohn ventures
Michigan Economic Development Corporation
Apjohn ventures
Michigan Economic Development Corporation
1/2014 Series C 1 $12M Capital Midwest Fund
Capital Midwest Fund
5/2005 Venture Round 1 $2.5M Apjohn ventures
Apjohn ventures
12/2004 Venture Round 1 $775k Apjohn ventures
Apjohn ventures
1/2022 Post-IPO Equity $135M
6/2013 Debt Financing $4.3M
8/2021 Post-IPO Equity $34M
11/2019 Post-IPO Equity $103M
3/2015 Debt Financing $2.7M
1/2022 Post-IPO Debt 1 $125M Oxford Finance LLC
Oxford Finance LLC
Oxford Finance LLC
Oxford Finance LLC
12/2010 Venture Round $1.7M
4/2014 Series D 9 $59.5M Frazier Healthcare Partners
RA Capital Management
Hopen Life Science Ventures
Capital Midwest Fund
Apjohn ventures
Vivo Capital
Janus Capital Group
The Amherst Fund
OrbiMed
Vivo Capital
Frazier Healthcare Partners
RA Capital Management
Hopen Life Science Ventures
Capital Midwest Fund
Apjohn ventures
Vivo Capital
Janus Capital Group
The Amherst Fund
OrbiMed
Vivo Capital
5/2008 Venture Round 2 $12.5M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research